
Elixacell Therapeutics Private Limited
Founded in February 2025 and headquartered in West Bengal, India.
Founded in February 2025 and headquartered in West Bengal, India.
Elixacell Therapeutics Private Limited (ETPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2025 ( one month 13 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raushan Sinha and Supriya Sadhukhan serve as directors at the Company.
Kolkata, West Bengal, India
+91-XXXXXXXXXX
U21000WB2025PTC276831
276831
Private Limited Indian Non-Government Company
25 Feb 2025
-
-
Unlisted
Roc Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Raushan Sinha ![]() | Director | 25-Feb-2025 | Current |
Supriya Sadhukhan | Director | 25-Feb-2025 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Elixacell Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Elixacell Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Elixacell Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixacell Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Raushan Kumar Sinha was appointed as a Director was appointed as a Director on 25 Feb 2025 & has been associated with this company since 1 month 13 days .
Supriya Sadhukhan was appointed as a Director was appointed as a Director on 25 Feb 2025 & has been associated with this company since 1 month 13 days .
Elixacell Therapeutics Private Limited was registered on 25 Feb 2025 with Roc Kolkata & aged 1 month 13 days as per MCA records.
Elixacell Therapeutics Private Limited was incorporated on 25 Feb 2025.
The authorized share capital of Elixacell Therapeutics Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Elixacell Therapeutics Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Elixacell Therapeutics Private Limited is 13E Santosh Roy Road South 24 Parganas, India, Kolkata, West Bengal, 700008.
The corporate identification number (CIN) of Elixacell Therapeutics Private Limited is U21000WB2025PTC276831 and the company number is 276831 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.